https://www.thebodypro.com/article/hiv-attachment-inhibitor-bms-663068-compares-well-
HIV Treatments in DevelopmentIDWeek

HIV Attachment Inhibitor BMS-663068 Compares Well to Boosted Atazanavir at 24 Weeks

    Myles Helfand

    Myles Helfand

    @MylesatTheBody

    Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.